Core Insights - Cosa Resources Corp. has reported positive results from ambient noise tomography (ANT) surveys at its Ursa and Orion uranium projects in the Athabasca Basin, Saskatchewan, indicating strong potential for uranium mineralization [1][3][4] Summary by Sections Project Overview - Cosa Resources holds 100% ownership of the Ursa and Orion uranium projects, which are located in the Athabasca Basin, a region known for its uranium deposits [1][3] ANT Survey Results - The ANT surveys have successfully identified high-priority target areas at both Ursa and Orion, demonstrating the effectiveness of modern geophysical methods in generating lower-risk drill targets compared to traditional electromagnetic surveys [3][4][8] - At Ursa, two significant target areas have been highlighted along a mineralized trend, with the U1 anomaly showing over 100 meters of continuous sandstone alteration and increased uranium content [5][6][8] - The U2 anomaly, approximately 2 kilometers long, is located above a conductive trend and has historical drilling results indicating uranium enrichment [9] Target Areas - At Orion, three priority target areas (O1, O2, O3) have been identified, characterized by low velocity anomalies that suggest potential uranium-bearing hydrothermal systems [10][11][12][13] - Target O1 measures approximately 1,700 by 800 meters, while O2 and O3 measure approximately 1,800 by 900 meters and 1,600 by 700 meters, respectively [11][12][13] Next Steps - The company plans to conduct ground EM surveying at Ursa to refine targets before follow-up diamond drilling, while at Orion, a reinterpretation of historical surveys will be undertaken to finalize drill targets [14] - Cosa's immediate focus includes an expanded summer drill program at the Murphy Lake North Joint Venture, which is expected to follow up on promising results from winter 2025 drilling [14][15] Company Background - Cosa Resources operates in northern Saskatchewan, with a portfolio of approximately 237,000 hectares across multiple projects, most of which are underexplored and located within established uranium corridors [20] - In January 2025, the company entered a strategic collaboration with Denison Mines, enhancing its access to additional prospective uranium exploration projects [21] - The management team has a proven track record in uranium exploration, having previously contributed to significant discoveries in the region [22]

Core Viewpoint - The company is accelerating its strategic transformation towards becoming an industrial AI company, enhancing its global presence, and entering the humanoid robot market [1][4]. Financial Performance - In the previous year, the company achieved a revenue of 9.139 billion yuan, a year-on-year increase of approximately 6%, and a net profit attributable to shareholders of 1.117 billion yuan, up 1.38% year-on-year [1]. - Excluding the impact of GDR foreign exchange gains and losses, the net profit attributable to shareholders was 1.092 billion yuan, representing a year-on-year growth of 9.60% [1]. Strategic Initiatives - The year 2025 is identified as a critical period for the company's strategic shift, with increased R&D investment in AI technology leading to short-term performance pressure but positioning the company for future growth [1]. - The company has launched innovative products such as the UCS universal control system and the TPT temporal industrial model, aimed at enhancing AI applications in process industries [2]. Product Innovations - The UCS system reduces cabinet room space by 90%, shortens construction time by 50%, and increases communication speed by over 100 times, representing a revolutionary innovation in control systems [2]. - The TPT model achieves a self-control rate of over 95%, reduces nitrogen oxide emissions by 5%, and decreases coal consumption by over 3.1%, providing significant economic benefits to clients [2]. Market Outlook - According to Omdia, the AI software market is expected to experience explosive growth, reaching a scale of 218 billion USD by 2029, driven by the integration of industrial AI models and agents [3]. - The company is actively promoting the development and application of TPT and robotics, anticipating these technologies will drive new growth [3]. Humanoid Robotics - The company has invested in the Zhejiang Humanoid Robot Innovation Center, which has launched two generations of humanoid robots and is moving towards mass production [4]. - The company has introduced the "Plantbot" solution, integrating AI and robotics to enhance perception, decision-making, and execution capabilities [4]. Global Expansion - In 2024, the company's overseas revenue reached 749 million yuan, a year-on-year increase of 118.27%, accounting for 8.25% of total revenue [5]. - The company has established 21 subsidiaries and 5 new 5S stores in various regions, enhancing the global influence of the SUPCON brand [5]. Strategic Partnerships - The company has formed deep collaborations with international clients such as Saudi Aramco and Petronas in various fields including control systems and industrial software [6]. - The company is pursuing acquisitions and partnerships to support its strategic transformation towards industrial AI and robotics [6].

Tesla’s sales in Europe plunged in April as the electric car maker faced backlash over Elon Musk’s political work and rising competition from China-based rival BYD.Tesla sold just 7,261 cars in the region last month – down from 14,228 units sold in the same month one year ago, according to data from the European Automobile Manufacturers Association.The April sales figures marked the fourth straight month of declines for Tesla in Europe. Sales have fallen by nearly 39% since the start of the year. 3 Elon M ...

TEL AVIV, Israel, May 27, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced today the publication of a Japanese divisional patent. The patent application introduces a novel pharmaceutical combination of paracetamol and palmitoylethanolamide (PEA) that may enhance pain relief and fever relief with lower doses an ...

Tesla (NASDAQ: TSLA) stock could decline over 40%, according to the outlook by banking giant UBS, which reaffirmed its bearish stance on the electric vehicle (EV) manufacturer. In an investor note on May 27, UBS analyst Joseph Spak reiterated his 'Sell' rating on Tesla, maintaining a price target of $190 per share, a 43% drop from the last market closing value of $339. Finbold Meanwhile, Tesla's image has taken a hit in Europe, with UBS attributing the damage partly to CEO Elon Musk's political statements a ...

May 20, 2025 10:00 PM GMT China Autos & Shared Mobility: Investor Presentation | Asia Pacific Japan Summit – AI-Enabled Mobility & Humanoid Robotics | M | | | | --- | --- | --- | | | | Update | | May 20, 2025 10:00 PM GMT | | | | China Autos & Shared Mobility: Investor | Morgan Stanley Asia Limited+ | | | Presentation Asia Pacific | Tim Hsiao | | | | Equity Analyst | | | | Tim.Hsiao@morganstanley.com | +852 2848-1982 | | Japan Summit – AI-Enabled | Stanley Wang Research Associate | | | | Stanley.Wang@morgan ...

Core Viewpoint - Tesla's shares have declined 15% year to date due to market share losses and external challenges, but there are optimistic projections regarding its future value and market position in autonomous driving and robotics [1][3][5]. Market Performance - Tesla lost 7 percentage points of market share in the first quarter, falling behind BYD in electric car sales as demand weakened in China, Europe, and the U.S. [1] - The company's production of the Model Y was limited due to factory updates, contributing to market share losses [2]. Leadership and Strategic Focus - CEO Elon Musk's political involvement and external tariffs imposed by President Trump have created additional challenges for Tesla [2]. - Musk has expressed confidence that Tesla will become the most valuable company globally, potentially surpassing the combined value of the top five companies, which currently total $14 trillion [5]. Future Projections - Analyst Dan Ives raised Tesla's target price to $500 per share, indicating a potential 47% upside from the current price of $339, citing the upcoming robotaxi launch as a key factor [3]. - Musk believes that Tesla's autonomous driving and robotics capabilities could significantly enhance its financial performance by the second half of next year [7]. Autonomous Driving and Market Strategy - Tesla plans to launch its first autonomous ride-sharing service in Austin, Texas, with expansion to other cities by year-end [7]. - Musk predicts that Tesla could achieve a 99% market share in the robotaxi sector due to its data advantages and cost-effective technology [8]. Business Model Innovation - Tesla's autonomous ride-sharing model will incorporate a crowdsourcing approach, allowing Tesla owners to add or remove their vehicles from the fleet [9]. Earnings Expectations - Wall Street anticipates Tesla's earnings to grow by 13% annually through 2026, although the current valuation appears high at 150 times earnings [10]. - Investors are encouraged to assess whether they believe Tesla can successfully transition into AI and robotics [10]. Investment Considerations - Investors who believe in Tesla's potential to disrupt the mobility and labor markets with autonomous technology are advised to consider owning the stock [11].

The obesity market has garnered much interest lately, propelled by the success of GLP-1 therapies Wegovy and Zepbound, marketed by pharma giants Novo Nordisk (NVO) and Eli Lilly (LLY) , respectively. This space is growing at an exponential pace and is expected to reach $100 billion by 2030.The soaring demand for weight-loss drugs has pushed companies to innovate beyond GLP-1s. One emerging area of interest is cannabinoid (CBD)-based therapies, which may unlock new mechanisms for managing weight and metaboli ...

用关注决定视界｜复杂世界的策展人 以下文章来源于那个NG ，作者那个NG 那个NG . 根据佐治亚州的法律规定，一旦检测到胎儿的心脏活动，就禁止女性堕胎，而亲属却无权决定是否继续使用生 命支持系统。这让该女子的家人感到不满。 那個NG: 今年最窒息的新闻：根据堕胎法，一位脑死亡女性被要求必须分娩 这可能是今年最窒息的一条新闻了。 美国佐治亚州一名孕妇在一次医疗紧急情况后被宣布脑死亡，但她却不能真正死去——她依赖体外生命支持系 统维持了三个月生命，只因为她的肚子里有一个胎儿。 她的家人说，医院告诉他们，根据佐治亚州严格的反堕胎法案，医院必须维持该女子的生命体征。 医生告诉史密斯的家人，他们不能停止或移除维持史密斯生命的装置，因为该州法律禁止在检测到心脏活动后 进行堕胎——通常也就是怀孕6周左右。 佐治亚州的法律赋予胎儿人格权。支持人格权的人认为，受精卵、胚胎和胎儿应该被视为与已出生的人享有同 等权利的人。 历史首例：比利时中世纪妓院遗迹中发现一具婴儿遗骨 佐治亚州参议员埃德·塞茨勒 (Ed Setzler) 是一名共和党人，也是2019年该法案的发起人。 他表示："我认为医院尽其所能挽救孩子的生命是完全合理的， ...

FRP Holdings, Inc. Investor Day MAY 22, 2025 Safe Harbor Disclosures Investors are cautioned that any statements in this press release which relate to the future are, by their nature, subject to risks and uncertainties that could cause actual results and events to differ materially from those indicated in such forward-looking statements. These include, but are not limited to: the possibility that we may be unable to find appropriate investment opportunities; levels of construction activity in the markets se ...